VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
+8.13%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.07B
AUM Growth
+$1.07B
(+6.4%)
Cap. Flow
+$51.8M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
64.05%
Holding
53
New
4
Increased
9
Reduced
7
Closed
7
Top Buys
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$25.4M |
| 2 |
MDCO
Medicines Co
MDCO
|
$24.4M |
| 3 |
Zymeworks
ZYME
|
$18.3M |
| 4 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$17.8M |
| 5 |
Insmed
INSM
|
$14.8M |
Top Sells
Sector Composition
| 1 | Healthcare | 94.71% |
| 2 | Materials | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $237M | 22.23% | 2,060,135 +13,303 | +0.6% | +$1.53M |
|
2
Crinetics Pharmaceuticals
CRNX
$2.92B
| $84.4M | 7.91% | 3,375,169 | – | – |
|
3
Arrowhead Research
ARWR
$3.05B
| $73.3M | 6.87% | 2,765,153 +436,678 | +19% | +$11.6M |
|
|
TCDA
4
DELISTED
Tricida, Inc. Common Stock
TCDA
| $56.2M | 5.27% | 1,424,525 +643,340 | +82% | +$25.4M |
|
5
Codexis
CDXS
$246M
| $48.2M | 4.52% | 2,614,458 -4,493 | -0.2% | -$82.8K |
|
|
6
Insmed
INSM
$28.8B
| $44.8M | 4.19% | 1,748,174 +577,884 | +49% | +$14.8M |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $39.2M | 3.68% | 1,600,000 | – | – |
|
|
SVA
8
DELISTED
Sinovac Biotech, Ltd
SVA
| $38.2M | 3.58% | 5,900,000 | – | – |
|
|
9
Zymeworks
ZYME
$1.12B
| $32M | 3% | 1,453,467 +833,333 | +134% | +$18.3M |
|
10
KalVista Pharmaceuticals
KALV
$678M
| $30.1M | 2.82% | 1,359,149 | – | – |
|
|
KDMN
11
DELISTED
Kadmon Holdings, Inc.
KDMN
| $26M | 2.43% | 12,606,605 | – | – |
|
|
MDCO
12
DELISTED
Medicines Co
MDCO
| $24.4M | 2.29% | +669,012 | New | +$24.4M |
|
13
VYNE Therapeutics
VYNE
$8.16M
| $24M | 2.25% | 4,011,236 | – | – |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $24M | 2.25% | 233,045 -18,062 | -7% | -$1.86M |
|
|
AMRS
15
DELISTED
Amyris Inc.
AMRS
| $23.1M | 2.17% | 6,490,557 +914,772 | +16% | +$3.26M |
|
16
Q32 Bio
QTTB
$20.9M
| $22.7M | 2.13% | 1,159,742 | – | – |
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $19M | 1.78% | 1,791,257 | – | – |
|
|
ORTX
18
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $18.4M | 1.72% | 1,312,084 +830,475 | +172% | +$11.6M |
|
|
CHMA
19
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $17.8M | 1.66% | +2,377,213 | New | +$17.8M |
|
|
CBAY
20
DELISTED
Cymabay Therapeutics
CBAY
| $15.4M | 1.45% | 2,154,934 +98,934 | +5% | +$708K |
|
21
MEI Pharma
MEIP
$160M
| $14.2M | 1.33% | 5,681,397 -96,709 | -2% | -$242K |
|
22
Xenon Pharmaceuticals
XENE
$2.98B
| $13.9M | 1.3% | 1,405,476 | – | – |
|
23
Aurinia Pharmaceuticals
AUPH
$1.58B
| $12.6M | 1.18% | 1,913,623 +700,333 | +58% | +$4.61M |
|
24
Soleno Therapeutics
SLNO
$3.6B
| $12M | 1.12% | 4,268,959 -90,724 | -2% | -$254K |
|
25
Rocket Pharmaceuticals
RCKT
$354M
| $11.8M | 1.11% | +786,712 | New | +$11.8M |
|